Seth Van-Voorhees, CFO & VP-Business Development at Research Frontiers, holds 46.34K shares in NRX Pharmaceuticals (Ticker: NRXP), holds 17.65K shares in PDS Biotechnology (Ticker: PDSB), holds 230.45K shares in Research Frontiers (Ticker: REFR). Most recently, Seth Van-Voorhees Bought ― shares of NRX Pharmaceuticals on Dec 19, 2022 for an estimated value of 33.00K.
Seth Van-Voorhees latest transaction was an Informative Buy of $33.00K.
What was Seth Van-Voorhees's most profitable transaction?
Seth Van-Voorhees’s most profitable transaction was an Informative Buy of REFR stock on September 13, 2017. The return on the trade was 23.20%.
What is Seth Van-Voorhees's role in Research Frontiers?
Seth Van-Voorhees's role in Research Frontiers is CFO & VP-Business Development.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.